Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2013

Open Access 01-12-2013 | Research article

Beyond case fatality rate: using potential impact fraction to estimate the effect of increasing treatment uptake on mortality

Authors: Nicholas Mitsakakis, Harindra C Wijeysundera, Murray Krahn

Published in: BMC Medical Research Methodology | Issue 1/2013

Login to get access

Abstract

Background

IMPACT is an epidemiological model that has been used to estimate how increased treatment uptakes affect mortality and related outcomes. The model calculations require the use of case fatality rate estimates under no treatment. Due to the lack of data, rates where treatment is partially present are often used instead, introducing bias. A method that does not rely on no-treatment case fatality rate estimates is needed.

Methods

Potential Impact Fraction (PIF) measures the proportional reduction in the disease or mortality risk, when the distribution of a risk factor changes. Here, we first describe a probabilistic framework for interpreting quantities used in the IMPACT model, and then we show how this is connected with PIF, facilitating its use for the estimation of the relative reduction of mortality caused by treatment uptake increase. We compare the proposed and standard methods to estimate the reduction of cardiovascular disease deaths in Ontario, if utilization of coronary heart disease interventions was increased to the level of 90%.

Results

Using the proposed method, we estimated that increasing treatment to benchmark levels uptake results in a reduction of 22.5% in cardiovascular mortality. The standard method gives a reduction of 20.8%.

Conclusions

Here we present an alternative method for the estimation of the effect of treatment uptake change on mortality. Our example suggests that the bias associated with the standard method may be substantial. This approach offers a useful tool for epidemiological and health care research and policy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Capewell S, Pell JP, Morrison C, McMurray J: Increasing the impact of cardiological treatments: how best to reduce deaths. Eur Heart J. 1999, 20 (19): 1386-1392. 10.1053/euhj.1999.1631.CrossRefPubMed Capewell S, Pell JP, Morrison C, McMurray J: Increasing the impact of cardiological treatments: how best to reduce deaths. Eur Heart J. 1999, 20 (19): 1386-1392. 10.1053/euhj.1999.1631.CrossRefPubMed
2.
go back to reference Unal B, Critchley J, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales, 1981–2000. Circulation. 2004, 109: 1101-1107. 10.1161/01.CIR.0000118498.35499.B2.CrossRefPubMed Unal B, Critchley J, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales, 1981–2000. Circulation. 2004, 109: 1101-1107. 10.1161/01.CIR.0000118498.35499.B2.CrossRefPubMed
3.
go back to reference Critchley J, Liu J, Zhao D, Wei W, Capewell S: Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999. Circulation. 2004, 110: 1236-1244. 10.1161/01.CIR.0000140668.91896.AE.CrossRefPubMed Critchley J, Liu J, Zhao D, Wei W, Capewell S: Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999. Circulation. 2004, 110: 1236-1244. 10.1161/01.CIR.0000140668.91896.AE.CrossRefPubMed
4.
go back to reference Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S: Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007, 356 (23): 2388-2398. 10.1056/NEJMsa053935.CrossRefPubMed Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S: Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007, 356 (23): 2388-2398. 10.1056/NEJMsa053935.CrossRefPubMed
5.
go back to reference Kottke TE, Faith DA, Jordan CO, Pronk NP, Thomas RJ, Capewell S: The Comparative Effectiveness of Heart Disease Prevention and Treatment Strategies. Am J Prev Med. 2009, 36 (1): 82-88. 10.1016/j.amepre.2008.09.010.CrossRefPubMed Kottke TE, Faith DA, Jordan CO, Pronk NP, Thomas RJ, Capewell S: The Comparative Effectiveness of Heart Disease Prevention and Treatment Strategies. Am J Prev Med. 2009, 36 (1): 82-88. 10.1016/j.amepre.2008.09.010.CrossRefPubMed
6.
go back to reference Capewell S, O’Flaherty M, Ford ES, Critchley JA: Potential reductions in United States coronary heart disease mortality by treating more patients. Am J Cardiol. 2009, 103 (12): 1703-1709. 10.1016/j.amjcard.2009.02.036.CrossRefPubMed Capewell S, O’Flaherty M, Ford ES, Critchley JA: Potential reductions in United States coronary heart disease mortality by treating more patients. Am J Cardiol. 2009, 103 (12): 1703-1709. 10.1016/j.amjcard.2009.02.036.CrossRefPubMed
7.
go back to reference Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G, Tu JV, Lee DS, Goodman SG, Petrella R, O’Flaherty M, Krahn M, Capewell S: Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994–2005. JAMA. 2010, 303 (18): 1841-1847. 10.1001/jama.2010.580.CrossRefPubMed Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G, Tu JV, Lee DS, Goodman SG, Petrella R, O’Flaherty M, Krahn M, Capewell S: Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994–2005. JAMA. 2010, 303 (18): 1841-1847. 10.1001/jama.2010.580.CrossRefPubMed
8.
go back to reference Wijeysundera HC, Mitsakakis N, Witteman W, Paulden M, van der Velde G, Tu JV, Lee DS, Goodman SG, Petrella R, O’Flaherty M, Capewell S, Krahn M: Achieving Quality Indicator Benchmarks and Potential Impact on Coronary Heart Disease Mortality. Can J Cardiol. 2011, 27 (6): 756-762. 10.1016/j.cjca.2011.06.005.CrossRefPubMed Wijeysundera HC, Mitsakakis N, Witteman W, Paulden M, van der Velde G, Tu JV, Lee DS, Goodman SG, Petrella R, O’Flaherty M, Capewell S, Krahn M: Achieving Quality Indicator Benchmarks and Potential Impact on Coronary Heart Disease Mortality. Can J Cardiol. 2011, 27 (6): 756-762. 10.1016/j.cjca.2011.06.005.CrossRefPubMed
9.
go back to reference Morgenstern H, Bursic ES: A method for using epidemiological data to estimate the potential impact of an intervention on the health status of a target population. J Community Health. 1982, 7 (4): 292-309. 10.1007/BF01318961.CrossRefPubMed Morgenstern H, Bursic ES: A method for using epidemiological data to estimate the potential impact of an intervention on the health status of a target population. J Community Health. 1982, 7 (4): 292-309. 10.1007/BF01318961.CrossRefPubMed
10.
go back to reference Eide GE, Heuch I: Attributable fractions: fundamental concepts and their visualization. Stat Methods Med Res. 2001, 10 (3): 159-193. 10.1191/096228001680195148.CrossRefPubMed Eide GE, Heuch I: Attributable fractions: fundamental concepts and their visualization. Stat Methods Med Res. 2001, 10 (3): 159-193. 10.1191/096228001680195148.CrossRefPubMed
11.
go back to reference Murray CJ, Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S: Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr. 2003, 1 (1): 1-10.1186/1478-7954-1-1.CrossRefPubMedPubMedCentral Murray CJ, Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S: Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr. 2003, 1 (1): 1-10.1186/1478-7954-1-1.CrossRefPubMedPubMedCentral
12.
go back to reference Mant J, Hicks N: Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ. 1995, 311: 793-796. 10.1136/bmj.311.7008.793.CrossRefPubMedPubMedCentral Mant J, Hicks N: Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ. 1995, 311: 793-796. 10.1136/bmj.311.7008.793.CrossRefPubMedPubMedCentral
13.
go back to reference Tuegels JL: Some Representations of the Multivariate Bernoulli and Binomial Distributions. J Multivar Anal. 1990, 32: 256-268. 10.1016/0047-259X(90)90084-U.CrossRef Tuegels JL: Some Representations of the Multivariate Bernoulli and Binomial Distributions. J Multivar Anal. 1990, 32: 256-268. 10.1016/0047-259X(90)90084-U.CrossRef
14.
go back to reference Levin ML: The occurrence of lung cancer in man. Acta Unio Internationalis Contra Cancrum. 1953, 9: 531-541.PubMed Levin ML: The occurrence of lung cancer in man. Acta Unio Internationalis Contra Cancrum. 1953, 9: 531-541.PubMed
15.
go back to reference Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C: Estimating the population attributable risk for multiple risk factors using case–control data. Am J Epidemiol. 1985, 122 (5): 904-914.PubMed Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C: Estimating the population attributable risk for multiple risk factors using case–control data. Am J Epidemiol. 1985, 122 (5): 904-914.PubMed
16.
17.
go back to reference Murray CJL, Lopez AD: On the Comparable Quantification of Health Risks: Lessons from the Global Burden of Disease Study. Epidemiology. 1999, 10 (5): 594-605. 10.1097/00001648-199909000-00029.CrossRefPubMed Murray CJL, Lopez AD: On the Comparable Quantification of Health Risks: Lessons from the Global Burden of Disease Study. Epidemiology. 1999, 10 (5): 594-605. 10.1097/00001648-199909000-00029.CrossRefPubMed
18.
go back to reference Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL: The Comparative Risk Assessment Collaborating Group: selected major risk factors and global and regional burden of disease. Lancet. 2002, 360 (9343): 1347-1360. 10.1016/S0140-6736(02)11403-6.CrossRefPubMed Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL: The Comparative Risk Assessment Collaborating Group: selected major risk factors and global and regional burden of disease. Lancet. 2002, 360 (9343): 1347-1360. 10.1016/S0140-6736(02)11403-6.CrossRefPubMed
19.
go back to reference Valent F, Little DA, Bertollini R, Nemer LE, Barbone F, Tamburlini G: Burden of disease attributable to selected environmental factors and injury among children and adolescents in Europe. Lancet. 2004, 363 (9426): 2032-2039. 10.1016/S0140-6736(04)16452-0.CrossRefPubMed Valent F, Little DA, Bertollini R, Nemer LE, Barbone F, Tamburlini G: Burden of disease attributable to selected environmental factors and injury among children and adolescents in Europe. Lancet. 2004, 363 (9426): 2032-2039. 10.1016/S0140-6736(04)16452-0.CrossRefPubMed
20.
go back to reference Haby MM, Vos T, Carter R, Moodie M, Markwick A, Magnus A, Tay-Teo KS, Swinburn B: A new approach to assessing the health benefit from obesity interventions in children and adolescents: the assessing cost-effectiveness in obesity project. Int J Obes (Lond). 2006, 30: 1463-1475. 10.1038/sj.ijo.0803469.CrossRef Haby MM, Vos T, Carter R, Moodie M, Markwick A, Magnus A, Tay-Teo KS, Swinburn B: A new approach to assessing the health benefit from obesity interventions in children and adolescents: the assessing cost-effectiveness in obesity project. Int J Obes (Lond). 2006, 30: 1463-1475. 10.1038/sj.ijo.0803469.CrossRef
21.
go back to reference Gachohi JM, Kitala PM, Ngumi PN, Skilton RA, Bett B: Population attributable fractions of farm vector tick (Rhipicephalus appendiculatus) presence on Theileria parva infection seroprevalence under endemic instability. Prev Vet Med. 2013, 108 (2–3): 103-113.CrossRefPubMed Gachohi JM, Kitala PM, Ngumi PN, Skilton RA, Bett B: Population attributable fractions of farm vector tick (Rhipicephalus appendiculatus) presence on Theileria parva infection seroprevalence under endemic instability. Prev Vet Med. 2013, 108 (2–3): 103-113.CrossRefPubMed
23.
go back to reference Mason CA, Tu S: Partitioning the population attributable fraction for a sequential chain of effects. Epidemiologic Perspectives & Innovations. 2008, 5: 5-10.1186/1742-5573-5-5.CrossRef Mason CA, Tu S: Partitioning the population attributable fraction for a sequential chain of effects. Epidemiologic Perspectives & Innovations. 2008, 5: 5-10.1186/1742-5573-5-5.CrossRef
24.
go back to reference Eide GE, Heuch I: Average attributable fractions: a coherent theory for apportioning excess risk to individual risk factors and subpopulations. Biom J. 2006, 48: 820-837. 10.1002/bimj.200510228.CrossRefPubMed Eide GE, Heuch I: Average attributable fractions: a coherent theory for apportioning excess risk to individual risk factors and subpopulations. Biom J. 2006, 48: 820-837. 10.1002/bimj.200510228.CrossRefPubMed
Metadata
Title
Beyond case fatality rate: using potential impact fraction to estimate the effect of increasing treatment uptake on mortality
Authors
Nicholas Mitsakakis
Harindra C Wijeysundera
Murray Krahn
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2013
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-13-109

Other articles of this Issue 1/2013

BMC Medical Research Methodology 1/2013 Go to the issue